Altimmune (ALT) Non-Current Debt (2012 - 2026)
Altimmune (ALT) reported Non-Current Debt of $34.5 million for Q1 2026, up 0.64% on a QoQ basis from $34.3 million in Q4 2025.
Altimmune (ALT) has 13 years of Non-Current Debt data on file, last reported at $34.5 million in Q1 2026.
- Quarterly Non-Current Debt changed N/A year-over-year to $34.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.5 million (changed N/A YoY) and the FY2025 annual result came in at $34.3 million, changed N/A from the prior year.
- Non-Current Debt rose to $34.5 million in Q1 2026 per ALT's latest filing, from $34.3 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $34.5 million in Q1 2026 and bottomed at $1.5 million in Q2 2022.
- The 4-year median for Non-Current Debt is $4.5 million (2022), against an average of $11.2 million.
- Peak annual rise in Non-Current Debt reached 215.06% in 2022, while the deepest fall reached 5.64% in 2022.
- Tracing ALT's Non-Current Debt over 4 years: stood at $4.6 million in 2022, then decreased by 6.02% to $4.3 million in 2023, then soared by 696.45% to $34.3 million in 2025, then grew by 0.64% to $34.5 million in 2026.
- Per Business Quant, the three latest ALT Non-Current Debt figures stand at $34.5 million (Q1 2026), $34.3 million (Q4 2025), and $14.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | 34.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.51 Mn |
| Mar 31, 2026 | 34.51 Mn |
| Dec 31, 2025 | 34.29 Mn |
| Dec 31, 2025 | 34.29 Mn |
| Sep 30, 2025 | 14.45 Mn |
| Sep 30, 2025 | 14.45 Mn |
| Jun 30, 2025 | 14.33 Mn |
| Jun 30, 2025 | 14.33 Mn |
| Sep 30, 2023 | 4.31 Mn |
| Sep 30, 2023 | 4.31 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 4.58 Mn |
| Dec 31, 2022 | 4.58 Mn |
| Sep 30, 2022 | 4.51 Mn |
| Sep 30, 2022 | 4.51 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 1.62 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 1.83 Mn |
| Dec 31, 2020 | 1.83 Mn |
| Sep 30, 2020 | 1.93 Mn |
| Sep 30, 2020 | 1.93 Mn |
| Jun 30, 2020 | 1.72 Mn |
| Jun 30, 2020 | 1.72 Mn |
| Mar 31, 2020 | 1.79 Mn |
| Mar 31, 2020 | 1.79 Mn |
| Dec 31, 2019 | 1.86 Mn |
| Dec 31, 2019 | 1.86 Mn |
| Sep 30, 2019 | 1.79 Mn |
| Sep 30, 2019 | 1.79 Mn |
| Jun 30, 2019 | 2.21 Mn |
| Jun 30, 2019 | 2.21 Mn |
| Mar 31, 2019 | 2.32 Mn |
| Mar 31, 2019 | 2.32 Mn |
| Dec 31, 2018 | 1.85 Mn |
| Dec 31, 2018 | 1.85 Mn |
| Sep 30, 2018 | 1.94 Mn |
| Sep 30, 2018 | 1.94 Mn |
| Jun 30, 2018 | 4.28 Mn |
| Jun 30, 2018 | 4.28 Mn |
| Mar 31, 2018 | 3.78 Mn |
| Mar 31, 2018 | 3.78 Mn |
| Dec 31, 2017 | 4.57 Mn |
| Dec 31, 2017 | 4.57 Mn |
| Sep 30, 2017 | 81,414.00 |
| Sep 30, 2017 | 81,414.00 |
| Jun 30, 2017 | 106,930.00 |
| Jun 30, 2017 | 106,930.00 |
| Dec 31, 2016 | 722,289.00 |
| Dec 31, 2016 | 722,289.00 |
| Jun 30, 2014 | 239,738.00 |
| Jun 30, 2014 | 239,738.00 |
| Mar 31, 2014 | 485,388.00 |
| Mar 31, 2014 | 485,388.00 |
| Dec 31, 2013 | 730,279.00 |
| Dec 31, 2013 | 730,279.00 |
| Sep 30, 2013 | 974,413.00 |
| Sep 30, 2013 | 974,413.00 |
| Jun 30, 2013 | 1.22 Mn |
| Jun 30, 2013 | 1.22 Mn |
| Mar 31, 2013 | 1.46 Mn |
| Mar 31, 2013 | 1.46 Mn |
| Dec 31, 2012 | 1.70 Mn |
| Dec 31, 2012 | 1.70 Mn |
| Sep 30, 2012 | 1.76 Mn |
| Sep 30, 2012 | 1.76 Mn |
| Jun 30, 2012 | 1.98 Mn |
| Jun 30, 2012 | 1.98 Mn |
| Mar 31, 2012 | 2.23 Mn |
| Mar 31, 2012 | 2.23 Mn |